A Study of the Effect of Different Doses of Difluprednate Eye Drops on the Intraocular Pressure After Phacoemulsification
Uveitis, Anterior
About this trial
This is an interventional treatment trial for Uveitis, Anterior
Eligibility Criteria
Inclusion Criteria: Age 40-80 Grade 1 to 4 nuclear cataract LOCS II Cumulative dissipated energy CDE 1 to 10 Done by a single surgeon using the chopping technique Exclusion Criteria: History of uveitis the use of topical or systemic steroids on the last post-operative day Intraoperative or postoperative complications Intraoperative iris manipulations or phaco traume
Sites / Locations
- Kafrelsheikh UniversityRecruiting
Arms of the Study
Arm 1
Arm 2
Active Comparator
Active Comparator
Group A
Group B
will receive Difluprednate 4 times per day for 1 week, then twice per day for 1 week and then once per day for 5 days starting 24 hours after the operation
will receive Difluprednate 3 times per day for 4 days, then twice per day for 4 days and then once per day for 4 days starting 4 hours after the operation